journal article·2019-04-25Open access

Adsorption of Proteins on m-CPPD and Urate Crystals Inhibits Crystal-Induced Cell Responses: Study on Albumin-Crystal Interaction

Felix Renaudin, Stéphanie Sarda, Laure Campillo-Gimenez, Childérick Séverac, Thibaut Léger, Cédric Charvillat, Christian Rey, Frédéric Lioté, Jean-Michel Camadro, Hang-Korng Ea, Christèle Combes

Abstract

The biological effects and cellular activations triggered by monosodium urate (MSU) and calcium pyrophosphate dihydrate (monoclinic: m-CPPD) crystals might be modulated by protein coating on the crystal surface. This study is aimed at: (i) Identifying proteins adsorbed on m-CPPD crystals, and the underlying mechanisms of protein adsorption, and (ii) to understand how protein coating did modulate the inflammatory properties of m-CPPD crystals. The effects of protein coating were assessed in vitro using primary macrophages and THP1 monocytes. Physico-chemical studies on the adsorption of bovine serum albumin (BSA) upon m-CPPD crystals were performed. Adsorption of serum proteins, and BSA on MSU, as well as upon m-CPPD crystals, inhibited their capacity to induce interleukin-1-β secretions, along with a decreased ATP secretion, and a disturbance of mitochondrial membrane depolarization, suggesting an alteration of NLRP3 inflammasome activation. Proteomic analysis identified numerous m-CPPD-associated proteins including hemoglobin, complement, albumin, apolipoproteins and coagulation factors. BSA adsorption on m-CPPD crystals followed a Langmuir-Freundlich isotherm, suggesting that it could modulate m-CPPD crystal-induced cell responses through crystal/cell-membrane interaction. BSA is adsorbed on m-CPPD crystals with weak interactions, confirmed by the preliminary AFM study, but strong interactions of BSA molecules with each other occurred favoring crystal agglomeration, which might contribute to a decrease in the inflammatory properties of m-CPPD crystals. These findings give new insights into the pathogenesis of crystal-related rheumatic diseases and subsequently may open the way for new therapeutic approaches.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Gout, Hyperuricemia, Uric Acid · Muscle and Compartmental Disorders · Abdominal Trauma and Injuries

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Université Paris 7 Denis Diderot, Inserm UMR 1132 Bioscar, Hôpital Lariboisière, Centre Viggo Petersen, 75010 Paris, France

CIRIMAT, Université de Toulouse, CNRS, Université Toulouse 3, Toulouse INP-ENSIACET, 31030 Toulouse, France

ITAV-CNRS, Université de Toulouse, CNRS, 31106 Toulouse, France

Institut Jacques Monod, UMR7592 CNRS, Université Paris Diderot, 75013 Paris, France

Funding

Agence Nationale de la Recherche

References (59)

Show source-provided references
1. The prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint10.1016/j.joca.2014.04.022 ↗
2. An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease10.1093/rheumatology/kep081 ↗
3. Global epidemiology of gout: Prevalence, incidence and risk factors10.1038/nrrheum.2015.91 ↗
4. Enhanced stability and local structure in biologically relevant amorphous materials containing pyrophosphate10.1039/c1jm13930d ↗
5. Structure of the beta form of calcium pyrophosphate tetrahydrate10.1107/S0108768100009447 ↗
6. Gras, P. (2014). Etude physico-chimique et structurale de pyrophosphates de calcium hydratés: Application aux micro-calcifications associées à l’arthrose. [Ph.D. Thesis, INP Toulouse]. (In French).
7. Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3 Inflammasome In Vitro10.4049/jimmunol.1001284 ↗
8. Gout-associated uric acid crystals activate the NALP3 inflammasome
9. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: Terminology and diagnosis10.1136/ard.2010.139105 ↗
10. The shape and size of hydroxyapatite particles dictate inflammatory responses following implantation10.1038/s41598-017-03086-0 ↗
11. Calcium phosphate particle induction of metalloproteinase and mitogenesis: Effect of particle sizes10.1016/S1063-4584(97)80009-X ↗
12. Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages10.1016/j.atherosclerosis.2007.02.005 ↗
13. Calcium pyrophosphate and monosodium urate crystal interactions with neutrophils: Effect of crystal size and lipoprotein binding to crystals
14. Comparison of the acute inflammation induced by calcium pyrophosphate dihydrate, apatite and mixed crystals in the rat air pouch model of a synovial space
15. TLR2 Signaling in Chondrocytes Drives Calcium Pyrophosphate Dihydrate and Monosodium Urate Crystal-Induced Nitric Oxide Generation10.4049/jimmunol.174.8.5016 ↗
16. Release of Collagenase, Neutral Protease, and Prostaglandins from Cultured Mammalian Synovial Cells by Hydroxyapatite and Calcium Pyrophosphate Dihydrate Crystals10.1002/art.1780241102 ↗
17. Campillo-Gimenez, L., Renaudin, F., Jalabert, M., Gras, P., Gosset, M., Rey, C., Sarda, S., Collet, C., Cohen-Solal, M., and Combes, C. (2018). Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-κB Activation and MAPK Pathways. Front. Immunol., 9.10.3389/fimmu.2018.02248 ↗
18. Inhibition and prevention of monosodium urate monohydrate crystal–induced acute inflammation in vivo by transforming growth factor β110.1002/art.1780390718 ↗
19. Inflammatory reactions induced by various calcium pyrophosphate crystals10.1016/0753-3322(90)90207-P ↗
20. Evidence for a causal relationship between the structure, size, and load of calcium pyrophosphate dihydrate crystals, and attacks of pseudogout10.1136/ard.54.10.825 ↗
21. Protein adsorption to monosodium urate, calcium pyrophosphate dihydrate, and silica crystals. Relationship to the pathogenesis of crystal-induced inflammation10.1002/1529-0131(197605/06)19:3+<433::AID-ART1780190718>3.0.CO;2-U ↗
22. Protein binding to monosodium urate monohydrate, calcium pyrophosphate dihydrate, and silicon dioxide crystals. I. Physical characteristics
23. Apolipoprotein B mediates the capacity of low density lipoprotein to suppress neutrophil stimulation by particulates10.1016/S0021-9258(18)66768-7 ↗
24. Superoxide anion generation by human neutrophils exposed to monosodium urate. effect of protein adsorption and complement activation10.1002/art.1780250210 ↗
25. High-density lipoproteins inhibit urate crystal-induced inflammation in mice10.1136/annrheumdis-2013-203803 ↗
26. Products of polymorphonuclear cell injury inhibit IgG enhancement of monosodium urate-induced superoxide production10.1002/art.1780291208 ↗
27. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model10.1002/art.1780360912 ↗
28. Components generated locally as well as serum alter the phlogistic effect of monosodium urate crystals in vivo
29. Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals10.1172/JCI111380 ↗
30. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System10.1016/j.smim.2017.10.001 ↗
31. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system10.1016/j.ijpharm.2018.10.011 ↗
32. Enhancement of crystal induced neutrophil responses by opsonisation of calcium pyrophosphate dihydrate crystals10.1136/ard.52.8.599 ↗
33. The interaction of monoclinic calcium pyrophosphate dihydrate crystals with neutrophils10.1007/BF01409981 ↗
34. Adsorption of O-Phospho-L-Serine and L-Serine onto Poorly Crystalline Apatite10.1006/jcis.2001.7450 ↗
35. Surface properties of biomimetic nanocrystalline apatites; applications in biomaterials10.1016/j.pcrysgrow.2014.09.005 ↗
36. Adsorption of tranexamic acid on hydroxyapatite: Toward the development of biomaterials with local hemostatic activity10.1016/j.msec.2016.04.032 ↗
37. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way10.1073/pnas.0709684105 ↗
38. A role for mitochondria in NLRP3 inflammasome activation
39. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-110.1073/pnas.88.9.3671 ↗
40. Activation of NLRP3 inflammasome by crystalline structures via cell surface contact10.1038/srep07281 ↗
41. Receptor-independent, direct membrane binding leads to cell surface lipid sorting and Syk kinase activation in dendritic cells10.1016/j.immuni.2008.09.013 ↗
42. Crystal-induced inflammation: Studies of the mechanism of crystal-membrane interactions
43. Insights into the modeling of adsorption isotherm systems10.1016/j.cej.2009.09.013 ↗
44. Superparamagnetic iron-doped nanocrystalline apatite as a delivery system for doxorubicin10.1039/C5TB01524C ↗
45. Adsorption on apatitic calcium phosphates for drug delivery: Interaction with bisphosphonate molecules10.1007/s10856-014-5218-0 ↗
46. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout10.1002/art.24185 ↗
47. NLRP3 inflammasome activation in inflammaging10.1016/j.smim.2018.09.001 ↗
48. Plasma Protein Binding by Monosodium Urate Crystals10.1002/art.1780260612 ↗
49. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticularapo E and demonstration of apo E binding to urate crystals in vivo10.1172/JCI114971 ↗
50. Calcium pyrophosphate dihydrate crystals activate MAP kinase in human neutrophils: Inhibition of MAP kinase, oxidase activation and degranulation responses of neutrophils by taxol10.1046/j.1365-2567.1997.d01-2178.x ↗
51. Intracellular calcium oscillations in articular chondrocytes induced by basic calcium phosphate crystals lead to cartilage degradation10.1016/j.joca.2012.07.017 ↗
52. Characterization and membranolytic effects of triclinic calcium pyrophosphate dihydrate crystals
53. Cytosolic Ca2+ concentration determinations in neutrophils stimulated by monosodium urate and calcium pyrophosphate crystals: Effect of protein adsorption
54. Differential Membranolytic Effects of Microcrystalline Sodium Urate and Calcium Pyrophosphate Dihydrate10.1084/jem.133.1.100 ↗
55. Gold nanoparticle should understand protein corona for being a clinical nanomaterial10.1016/j.jconrel.2018.01.002 ↗
56. Winternitz, C.I. (1994). Calcium pyrophosphate dihydrate crystal deposition disease: Characterization and IgG binding properties of monoclinic calcium pyrophosphate dihydrate crystals. [Ph.D. Thesis, University of British Columbia].
57. Synthesis and Characterisation of Hydrated Calcium Pyrophosphate Phases of Biological Interest10.1002/ejic.201300955 ↗
58. Probing single molecule interactions by AFM using bio-functionalized dendritips10.1016/j.snb.2012.04.048 ↗
59. Calibration of atomic-force microscope tips10.1063/1.1143970 ↗